Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Date Insider Type Main position Quantity % Market Cap. Importance
09/07/20 Tender

Chief Executive Officer

29,206 0.1196%
09/07/20 Tender

Chief Financial Officer

500 0.0020% -
09/07/20 Tender

Director

102,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
+3.73%+5.03%-10.89%+14.80% 184B
+2.85%+4.75%+9.47%+37.73% 118B
+5.12%+0.22%-13.88%+10.27% 111B
+1.41%+6.80%-41.10%+6.45% 94.58B
+2.12%+2.38%+0.01%+75.79% 63.13B
-5.48%-5.11%-1.24%+61.88% 55.66B
+0.36%+1.13%+11.13%-22.40% 53.9B
+21.85%+17.79%+6.69%+60.13% 43.42B
+2.23%+4.24%+1.04%-8.32% 34.68B
Average +3.42%+4.23%-4.31%+26.26% 84.27B
Weighted average by Cap. +3.43%+4.06%-7.19%+24.09%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-